[Investigation regarding the influence of erythroblastosis fetalis on infant lung maturity (author's transl)].
D000653:Amniotic Fluid / Q000032:analysis; D001623:Betamethasone / Q000627:therapeutic use; D004487:Edema; D004899:Erythroblastosis, Fetal / Q000150:complications / Q000196:embryology*; D005260:Female; D005865:Gestational Age; D006801:Humans; D007231:Infant, Newborn; D008168:Lung / Q000196:embryology*; D010713:Phosphatidylcholines / Q000032:analysis; D010758:Phosphorus / Q000032:analysis; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D012127:Respiratory Distress Syndrome, Newborn / Q000209:etiology / Q000517:prevention & control; D012204:Rh-Hr Blood-Group System
D010713:Phosphatidylcholines; D012204:Rh-Hr Blood-Group System; D010758:Phosphorus; D001623:Betamethasone
Untersuchungen über den Einfluss der fetalen Erythroblastose auf die kindliche Lungenreife.